TABLE 1.
Clinical and demographic data of the PET/MR cohort.
| Age (y) | Gender | Disease Duration (m) | H-Y Scale | UPDRS III | MoCA | HAMA | HAMD-24 | RBDQ-HK | |
| HC (N = 31) | 57.45 ± 10.52 | 16F/15 M | – | – | 0.42 ± 1.31 | 25.10 ± 3.76 | 3.00 ± 4.86 | 1.93 ± 3.12 | 4.30 ± 5.68 |
| (36–71) | (0–4) | (14–30) | (0–25) | (0–14) | (0–25) | ||||
| PD (N = 34) | 58.29 ± 13.90 | 16F/18 M | 39.47 ± 40.69 | 1.77 ± 0.70 | 22.00 ± 11.75 | 26.65 ± 3.07 | 7.43 ± 8.14 | 6.73 ± 10.73 | 14.13 ± 14.25 |
| (26–86) | (6–171) | (1.0–4.0) | (7–55) | (16–30) | (0–39) | (0–58) | (0–53) | ||
| P | 0.41 | 0.84 | – | – | <0.05 | 0.20 | <0.05 | <0.05 | <0.05 |
H-Y Scale, Hoehn-Yahr scale; UPDRS III, motor score of unified Parkinson’s Disease rating scale; MoCA, Montreal cognitive assessment; HAMA, hamilton anxiety scale; HAMD-24, 24-item hamilton depression rating scale; RBDQ-HK, rapid eye movement sleep behavior disorder questionnaire-Hong Kong. Data are presented as mean ± SD, with ranges in parentheses.